Evidence map›Paper›PMID 36145771›Full record

ArticlePlants (Basel, Switzerland)2022

Phytochemical and Pharmacological Research in

Natalia Huzio, Andriy Grytsyk, Ain Raal, Lyubov Grytsyk, Oleh Koshovyi

Open access · goldAbstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. The benefits of multi-Analytical and bioanalytical chemistry · 2026
    Article
  3. Article
  4. Antibiofilm Activity ofInternational journal of microbiology · 2026
    Article
  5. Review
  6. Food science & nutrition · 2025
    Article
  7. Plants (Basel, Switzerland) · 2025
    Article
  8. German Chamomile (International journal of molecular sciences · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. American Cranberry (Plants (Basel, Switzerland) · 2023
    Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Natalia HuzioDepartment of Pharmaceutical Management, Drug Technology and Pharmacognosy, Ivano-Frankivsk National Medical University, 2 Halytska Str., 76018 Ivano-Frankivsk, Ukraine.
Andriy GrytsykDepartment of Pharmaceutical Management, Drug Technology and Pharmacognosy, Ivano-Frankivsk National Medical University, 2 Halytska Str., 76018 Ivano-Frankivsk, Ukraine.
Ain RaalInstitute of Pharmacy, Faculty of Medicine, University of Tartu, Nooruse 1, 50411 Tartu, Estonia.ORCID 0000-0001-8731-7366
Lyubov GrytsykDepartment of Pharmaceutical Management, Drug Technology and Pharmacognosy, Ivano-Frankivsk National Medical University, 2 Halytska Str., 76018 Ivano-Frankivsk, Ukraine.
Oleh KoshovyiDepartment of Pharmacognosy, The National University of Pharmacy, 53 Pushkinska St, 61002 Kharkiv, Ukraine.ORCID 0000-0001-9545-8548
Ivano-Frankivsk National Medical University · UANational University of Pharmacy · UAUniversity of Tartu · EE

Funding

Ivano-Frankivsk National Medical University, Ukraine 0118U003809Ministry of Health Care of Ukraine 2301020
6 · The paper itself

Abstract

The most promising plant from the genus Agrimony (

Indexed as

Agrimonia eupatoria L.biological active substancesextracthepatoprotective activityherb

Identifiers

PMID36145771
PMCPMC9502318
OpenAlexW4296012262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.